Therefore, we propose that the association of SFRP2 and increased ECV fraction could be reflective of SFRP2 acting as a compensatory factor (rather than a risk factor) to counteract myocardial fibrosis during the development of HF. This evidence concerns the gene SFRP2 and hydrops fetalis.